News About: Pharm. Industry
Celltrion Group Chairman Jung-Jin Seo starts to manage overseas businesses
Celltrion Group Chairman Jung-Jin Seo are visiting partnering companies in about 40 countries, and is discussing detailed business strategies about its products with CEOs and directors.
According to Celltrion Group, ...
KPBMA conducting check-up before the pharma industry job fair
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) is conducting a preliminary check-up on its member companies about details of their second half recruiting plan, such as number of people to rec...
Kolon Pharma signs KRW 14 billion co-promotion with Abbott Korea
Kolon Pharma(CEO Woo-Seok Lee) announced on the 20th that they signed a co-promotion agreement for 5 products including Klaricid Film Coated Film with Abbott Laboratories.
The agreed products are Klaricid Film Coated...
GC Pharm starts to ship flue vaccines for this season in Korea
Influenza(flu) vaccines have started to be shipped.
GC Pharm(CEO Eun-Cheol Huh) announced on the 20th that they have started to ship the 2018-2019 seasonal trivalent and tetravalent vaccines ‘GCFlu Prefilled Syringe ...
Unimed Pharm passes U.S. FDA’s onsite inspection for disposable artificial tears
A eye drop company Unimed Pharm(CEO Gun-Nam Kim) announced on the 20th that they successfully passed the U.S. FDA onsite inspection recently for the disposable eye drop ‘Carboxymethylcellulose sodium 0.5%.’
The compa...
Daewoong’s Nabota enters advanced market with Canadian approval
Daewoong Pharmaceutical’s Nabota has finally opened a new pharmaceutically advanced market.
Daewoong Pharmaceutical(CEO Seung-Ho Jeon) announced its self-developed botulinum toxin product ‘Nabota’ was approved from t...
One of 5 listed pharmas spending more than 10% of their sales into R&D
Listed pharmaceutical companies have been criticized to pay no attention in making investment into R&D.
Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceutical companies’ 2018 first half busines...
Green Cross Cell’s Immune Cell-LC designated as orphan drug for brain tumor from FDA
Green Cross Cell(Duk-Joo Lee), a cell therapy company, announced on the 17th that their ‘Immune Cell-LC’ was designated as orphan drug from the U.S. FDA on the 17th.
Immune Cell-LC acquired approval as an anticancer ...
Huons Jecheon Factory being selected for ‘Demo Project for Smart Factories’ for first time as pharma
Huons, a subsidiary of Huons Global(CEO Sung-Tae Yoon & Wan-Sup Kim), announced they were selected for the ‘Demo Project for Establishment of Smart Factories’ for the first time as a pharmaceutical company.
Located i...
AbbVie Korea recruits Executive Director Young-Shin Park as new general manager for immunology business
AbbVie Korea(CEO Hong-Ki Ryu) recruited Executive Director Young-Shin Park(47) as a general manager of its immunology business.
Executive Director Young-Shin Park generally managed the pharmaceutical department at Al...
